These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31482494)

  • 1. Quality Control and Downstream Processing of Therapeutic Enzymes.
    Gervais D
    Adv Exp Med Biol; 2019; 1148():55-80. PubMed ID: 31482494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commercialization of a novel fermentation concept.
    Mazumdar-Shaw K; Suryanarayan S
    Adv Biochem Eng Biotechnol; 2003; 85():29-42. PubMed ID: 12930092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and Purification of Therapeutic Enzymes.
    Taipa MÂ; Fernandes P; de Carvalho CCCR
    Adv Exp Med Biol; 2019; 1148():1-24. PubMed ID: 31482492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward microfluidic continuous-flow and intelligent downstream processing of biopharmaceuticals.
    Sharma V; Mottafegh A; Joo JU; Kang JH; Wang L; Kim DP
    Lab Chip; 2024 May; 24(11):2861-2882. PubMed ID: 38751338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Process intensification to produce a difficult-to-express therapeutic enzyme by high cell density perfusion or enhanced fed-batch.
    Särnlund S; Jiang Y; Chotteau V
    Biotechnol Bioeng; 2021 Sep; 118(9):3533-3544. PubMed ID: 33914903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a 30-year-old process for the manufacture of L-asparaginase from Erwinia chrysanthemi.
    Gervais D; Allison N; Jennings A; Jones S; Marks T
    Bioprocess Biosyst Eng; 2013 Apr; 36(4):453-60. PubMed ID: 22907565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward Higher QA: From Parametric Release of Sterile Parenteral Products to PAT for Other Pharmaceutical Dosage Forms.
    Hock SC; Constance NX; Wah CL
    PDA J Pharm Sci Technol; 2012; 66(4):371-91. PubMed ID: 22767885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomanufacturing process analytical technology (PAT) application for downstream processing: Using dissolved oxygen as an indicator of product quality for a protein refolding reaction.
    Pizarro SA; Dinges R; Adams R; Sanchez A; Winter C
    Biotechnol Bioeng; 2009 Oct; 104(2):340-51. PubMed ID: 19472303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Throughput Optimization of Continuous Biopharmaceutical Manufacturing Facilities.
    Garcia FA; Vandiver MW
    PDA J Pharm Sci Technol; 2017; 71(3):189-205. PubMed ID: 27974629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Online/at-line measurement, analysis and control of product titer and critical product quality attributes (CQAs) during process development.
    Chemmalil L; Prabhakar T; Kuang J; West J; Tan Z; Ehamparanathan V; Song Y; Xu J; Ding J; Li Z
    Biotechnol Bioeng; 2020 Dec; 117(12):3757-3765. PubMed ID: 32776503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stromal cell therapy: progress in manufacturing and assessments of potency.
    Robb KP; Fitzgerald JC; Barry F; Viswanathan S
    Cytotherapy; 2019 Mar; 21(3):289-306. PubMed ID: 30528726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three Rs potential in the development and quality control of immunobiologicals.
    Halder M
    ALTEX; 2001; 18 Suppl 1():13-47. PubMed ID: 11854853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in technology supporting biopharmaceutical production from mammalian cells.
    Butler M; Meneses-Acosta A
    Appl Microbiol Biotechnol; 2012 Nov; 96(4):885-94. PubMed ID: 23053101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Batch and fed-batch bioreactor studies for the enhanced production of glutaminase-free L-asparaginase from Pectobacterium carotovorum MTCC 1428.
    Kumar S; Prabhu AA; Dasu VV; Pakshirajan K
    Prep Biochem Biotechnol; 2017 Jan; 47(1):74-80. PubMed ID: 27070115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality assessment of recombinant proteins produced in plants.
    Medrano G; Dolan MC; Condori J; Radin DN; Cramer CL
    Methods Mol Biol; 2012; 824():535-64. PubMed ID: 22160919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Side-by-side comparability of batch and continuous downstream for the production of monoclonal antibodies.
    David L; Schwan P; Lobedann M; Borchert SO; Budde B; Temming M; Kuerschner M; Alberti Aguilo FM; Baumarth K; Thüte T; Maiser B; Blank A; Kistler V; Weber N; Brandt H; Poggel M; Kaiser K; Geisen K; Oehme F; Schembecker G
    Biotechnol Bioeng; 2020 Apr; 117(4):1024-1036. PubMed ID: 31930482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality control and analytical techniques for biopharmaceuticals.
    Robinson CJ; Jones C
    Bioanalysis; 2011 Jan; 3(1):81-95. PubMed ID: 21175369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gram-scale production of recombinant microbial enzymes in shake flasks.
    Chrast L; Chaloupkova R; Damborsky J
    FEMS Microbiol Lett; 2018 Feb; 365(2):. PubMed ID: 29228335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovative fermentation strategies for the production of extremophilic enzymes.
    Schiraldi C; Acone M; Giuliano M; Di Lernia I; Maresca C; Cartenì M; de Rosa M
    Extremophiles; 2001 Jun; 5(3):193-8. PubMed ID: 11453463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.